What is the Return on Assets (ROA) of Equillium this year?
The Return on Assets (ROA) of Equillium is -0.26 undefined this year.
Equillium ROA 2025
Equillium ROA
-0.26
Ticker
EQ
ISIN
US29446K1060
WKN
A2N7B3
In 2025, Equillium's return on assets (ROA) was -0.26, a -66.85% increase from the -0.8 ROA in the previous year.
Equillium Aktienanalyse
What does Equillium do?
Equillium Inc is an emerging biotechnology company specializing in the research and development of therapies for the treatment of inflammatory and autoimmune diseases. The company was founded in 2017 by a group of experienced biotech entrepreneurs who aim to develop innovative and effective treatment methods to improve patients' quality of life. Equillium's business model focuses on the discovery and development of new therapies based on the modulation of the CD6 signaling pathway, a central regulator of the immune system. Equillium's technology aims to modulate the immune system to suppress an inflammatory response associated with autoimmune and other inflammatory diseases. The company collaborates closely with leading university research laboratories and experts in the field to develop effective therapies. Equillium targets a wide range of disease areas, including autoimmune diseases such as lupus, psoriasis, and Crohn's disease. The company has also developed a program to treat COVID-19, aiming to reduce the immune-mediated inflammatory response associated with severe cases of COVID-19. Equillium's product portfolio includes EQ001, a monoclonal antibody used for the treatment of lupus and other autoimmune diseases. EQ001 blocks the CD6 signaling pathway, thereby reducing inflammatory responses that attack healthy tissues in the body. The company is also working on developing a novel platform technology to explore additional therapy options based on the CD6 signaling pathway. Equillium has a strong funding base and is supported by some of the most renowned biotech investors. The company has a comprehensive pipeline of potential therapies that are intended to address a variety of indications in the future. Overall, Equillium's advanced biotechnological research and development have contributed to the discovery of new and effective ways to treat inflammatory and autoimmune diseases. The company is well-positioned to expand in this area of medicine and improve therapy options for patients worldwide. Equillium ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Equillium's Return on Assets (ROA)
Equillium's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Equillium's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Equillium's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Equillium’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Equillium stock
What was the ROA of Equillium compared to the previous year?
The ROA of Equillium has increased by -66.85% compared to the previous year.
What consequences do high ROA have for investors of Equillium?
A high ROA is advantageous for investors of Equillium, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Equillium?
A low ROA can be unfavorable for investors of Equillium as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Equillium affect the company?
An increase in ROA of Equillium can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Equillium impact the company?
A reduction in the ROA of Equillium can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Equillium?
Some factors that can influence the ROA of Equillium include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Equillium important for investors?
The ROA of Equillium is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Equillium take to improve ROA?
To improve ROA, Equillium can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Equillium pay?
Over the past 12 months, Equillium paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Equillium is expected to pay a dividend of 0 USD.
What is the dividend yield of Equillium?
The current dividend yield of Equillium is .
When does Equillium pay dividends?
Equillium pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Equillium?
Equillium paid dividends every year for the past 0 years.
What is the dividend of Equillium?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Equillium located?
Equillium is assigned to the 'Health' sector.
Wann musste ich die Aktien von Equillium kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Equillium from 2/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/8/2025.
When did Equillium pay the last dividend?
The last dividend was paid out on 2/8/2025.
What was the dividend of Equillium in the year 2024?
In the year 2024, Equillium distributed 0 USD as dividends.
In which currency does Equillium pay out the dividend?
The dividends of Equillium are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Equillium
Our stock analysis for Equillium Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Equillium Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
